Fundraising FoxAltruBio
8 known investors
Find your way into AltruBio
Sign up to find every way you can get introduced to AltruBio
- Your email: who you already know at AltruBio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the AltruBio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
AltruBio develops antibody-based therapeutics for immunological and inflammatory diseases, with clinical-stage candidates (ALTB-268 and ALTB-168) targeting conditions such as ulcerative colitis, psoriatic arthritis, psoriasis, and acute graft versus host disease. Its programs are in preclinical through Phase II development.
Investors · 8
How we know: aMoon's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: funding news · deloscapital.com · Not right? Tell us
How we know: RA Capital's portfolio page · funding news · deloscapital.com · Not right? Tell us
How we know: funding news · fiercebiotech.com · Not right? Tell us
How we know: funding news · deloscapital.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$225M disclosed across 1 of 2 rounds · 2021–2024
- $225MSeries BMay 2024 · 5 sources
aMoon Fund (lead), BVF Partners (lead), Blackstone Multi-Asset Investing, Cormorant Asset Management, Delos Capital, RA Capital Management, Soleus Capital
Source ↗ - Undisclosed amountSeries AApr 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does AltruBio do?
- AltruBio develops antibody-based therapeutics for immunological and inflammatory diseases, with clinical-stage candidates (ALTB-268 and ALTB-168) targeting conditions such as ulcerative colitis, psoriatic arthritis, psoriasis, and acute graft versus host disease. Its programs are in preclinical through Phase II development.
- Who are AltruBio's investors?
- AltruBio's investors include aMoon, Delos Capital, RA Capital, Biotechnology Value Fund, Soleus Capital.
- How much funding has AltruBio raised?
- AltruBio has disclosed $225M raised across 1 of its 2 known rounds.